"Real life" use of raltegravir during pregnancy in France: The Coferal-IMEA048 cohort study (Q64095158)

1

object named as

Pierre Gantner

0 references

author name string

Babacar Sylla

2

0 references

Laurence Morand-Joubert

3

0 references

Pierre Frange

4

0 references

Karine Lacombe

5

0 references

Marie-Aude Khuong

6

0 references

Claudine Duvivier

7

0 references

Marina Karmochkine

9

0 references

Cédric Arvieux

10

0 references

Amélie Ménard

11

0 references

Lionel Piroth

12

0 references

Ana Canestri

13

0 references

Dominique Trias

14

0 references

Gilles Peytavin

15

0 references

Roland Landman

16

0 references

Jade Ghosn

Creative Commons Attribution 4.0 International

17

0 references

language of work or name

English

0 references

publication date

2019

0 references

published in

PLOS One

0 references

volume

14

0 references

issue

4

0 references

page(s)

e0216010

0 references

copyright license

start time

24 April 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Periconceptional exposure to efavirenz and neural tube defects

1 reference

12 December 2020

U.S. Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States

1 reference

12 December 2020

Association of Prenatal and Postnatal Exposure to Lopinavir-Ritonavir and Adrenal Dysfunction Among Uninfected Infants of HIV-Infected Mothers

1 reference

12 December 2020

Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?

1 reference

12 December 2020

Short communication: Use of raltegravir in late-presenting HIV-infected pregnant women

1 reference

12 December 2020

Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11)

1 reference

12 December 2020

Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis.

1 reference

12 December 2020

[Reproductive options for people living with HIV: 2013 guidelines from the French expert working group].

1 reference

12 December 2020

Comparing genotoxic signatures in cord blood cells from neonates exposed in utero to zidovudine or tenofovir

1 reference

12 December 2020

Raltegravir in HIV-1-Infected Pregnant Women: Pharmacokinetics, Safety, and Efficacy

1 reference

12 December 2020

No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception

1 reference

12 December 2020

Risk of cancer in children exposed to didanosine in utero

1 reference

12 December 2020

Integrase inhibitors in late pregnancy and rapid HIV viral load reduction

1 reference

12 December 2020

Critical Review: Review of the Efficacy, Safety, and Pharmacokinetics of Raltegravir in Pregnancy.

1 reference

12 December 2020

Advances in therapy for the prevention of HIV transmission from mother to child

1 reference

12 December 2020

Antiretroviral Therapy Containing Raltegravir to Prevent Mother-to-Child Transmission of HIV in Infected Pregnant Women

1 reference

12 December 2020

Treatment with integrase inhibitor suggests a new interpretation of HIV RNA decay curves that reveals a subset of cells with slow integration.

1 reference

12 December 2020

A Single-Center Retrospective Cohort Analysis of Maternal and Infant Outcomes in HIV-Infected Mothers Treated with Integrase Inhibitors During Pregnancy.

1 reference

12 December 2020

Protease inhibitors and preterm delivery: another piece in the puzzle.

1 reference

12 December 2020

Preconception use of cART by HIV-positive pregnant women increases the risk of infants being born small for gestational age.

1 reference

12 December 2020

Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0.

1 reference

12 December 2020

Intensification of antiretroviral treatment with raltegravir for pregnant women living with HIV at high risk of vertical transmission.

1 reference

12 December 2020

Neural-Tube Defects with Dolutegravir Treatment from the Time of Conception

1 reference

12 December 2020

1 reference

12 December 2020

Elvitegravir/cobicistat pharmacokinetics in pregnant and postpartum women with HIV

1 reference

12 December 2020

Birth Defects After Exposure to Efavirenz-Based Antiretroviral Therapy at Conception/First Trimester of Pregnancy: A Multicohort Analysis

1 reference

12 December 2020